Sunday 8 November 2026 Export OGN’s income statement to Excel — free account

Organon & Co.

OGN

Healthcare Drug Manufacturers General

Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024.

Revenue: −1.75%
EPS: +1.64%
Free cash flow: +118.8%
Total debt: −3.10%

Quarter to September 2026, against a year earlier

13.87 0.08 +0.58%

Follow OGN

Alert me

Market cap: $3.6B
P/E: 17.3×
Fwd P/E: 6.2×
Dividend yield: 0.58%
F-score: 5/9
ROIC: 6.26%
Net debt / EBITDA: 5.6×
Dividend safety: 45/100

Overview

Organon & Co. (OGN) P/B ratio

Alert me on P/B ratio

As of 6 November 2026, Organon & Co. (OGN) trades at a P/B ratio of 3.0×. Over the past ten years it has ranged from 0.0× (March 2024) to 117× (May 2024); the current reading is higher than 64% of that period. That is below the Drug Manufacturers General industry median of 5.3× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/OGN/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Organon &amp; Co. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/OGN/metrics/pb-ratio">Organon &amp; Co. (OGN) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	2.5×	(69.55%)
FY2024	8.1×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	1.8×	0.00%
FY2019	1.8×	0.00%
FY2018	1.8×	0.00%
FY2017	1.8×	—

Period	P/B ratio	Change
Sep 2026	3.0×	(14.68%)
Jun 2026	3.5×	104.65%
Mar 2026	1.7×	(30.20%)
Dec 2025	2.5×	(19.27%)
23 more quarters	Free account

Against its own ten years

Low 0.0× High 117×

Ten-year median 0.0×

Current reading's percentile 64

Company	P/B ratio
AMRN Amarin Corporation PLC compare	0.5×
GRFS Grifols, S.A. compare	0.6×
SNY Sanofi compare	1.4×
PFE Pfizer Inc. compare	1.9×
BIIB Biogen Inc. compare	1.9×
OGN Organon & Co.	3.0×
GSK GSK PLC Sponsored ADR compare	4.1×
NVO Novo Nordisk A/S compare	5.3×
BMY Bristol Myers Squibb Company compare	5.4×
Drug Manufacturers General industry median	5.3×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Organon & Co. (OGN) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on OGN

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on OGN

Stockrow Weekly